We report that in HCC cell lines, activation of TRPML1 function leads to cancer cell death by impairing mitochondrial function in a Ca2+-dependent manner and might therefore be beneficial in cancer therapy. This evidence concerns the gene MCOLN1 and hepatocellular carcinoma.